Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

NCT06263816 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT06263816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 17, 2025
Completion date
July 17, 2030
Enrollment
290 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic cirrhosis, clinically significant portal hypertension